{"disease":{"id":"hyposmia","name":"hyposmia"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04710394","title":"Visual-OLfactory Training in Participants With COVID-19 Resultant Loss of Smell","phase":"NA","overall_status":"COMPLETED","enrollment_count":240,"lead_sponsor_name":"Washington University School of Medicine","has_results":false},{"nct_id":"NCT05837637","title":"The Vietnamese Smell Identification Test in the Diagnosis of Parkinson's Disease","phase":"","overall_status":"UNKNOWN","enrollment_count":218,"lead_sponsor_name":"University Medical Center Ho Chi Minh City (UMC)","has_results":false},{"nct_id":"NCT04853836","title":"Olfactory Disfunction and Co-ultraPEALut","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"University Of Perugia","has_results":false},{"nct_id":"NCT05152030","title":"The Clinical Applicability of the 'TIB' Olfactory Test Device","phase":"","overall_status":"COMPLETED","enrollment_count":180,"lead_sponsor_name":"Taichung Veterans General Hospital","has_results":false},{"nct_id":"NCT06019000","title":"Study of CYR-064 Versus Placebo in Patients.","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":151,"lead_sponsor_name":"Cyrano Therapeutics, Inc.","has_results":false},{"nct_id":"NCT06142565","title":"Treatment of Postviral Olfactory Dysfunction","phase":"NA","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"Karolinska Institutet","has_results":false},{"nct_id":"NCT06600438","title":"Slow-SPEED UK: A Double-Blind Randomised Feasibility Trial","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":110,"lead_sponsor_name":"Queen Mary University of London","has_results":false},{"nct_id":"NCT05364125","title":"Olfactory Training on Smell Dysfunction Patients in HK","phase":"NA","overall_status":"RECRUITING","enrollment_count":80,"lead_sponsor_name":"Pamela Youde Nethersole Eastern Hospital","has_results":false},{"nct_id":"NCT05421221","title":"Olfactory Training in COVID-19 Associated Loss of Smell","phase":"NA","overall_status":"COMPLETED","enrollment_count":70,"lead_sponsor_name":"Medical University Innsbruck","has_results":false},{"nct_id":"NCT05184192","title":"Efficacy of Gabapentin for Post-Covid-19 Olfactory Dysfunction","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":68,"lead_sponsor_name":"Washington University School of Medicine","has_results":true},{"nct_id":"NCT07151703","title":"Topical Versus Injection PRP for Olfactory Dysfunction","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":60,"lead_sponsor_name":"Taipei Veterans General Hospital, Taiwan","has_results":false},{"nct_id":"NCT06733636","title":"Scents of Progress: Leveraging a Novel Device for Olfactory Training in Older Adults","phase":"NA","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Johns Hopkins University","has_results":false},{"nct_id":"NCT04661800","title":"Study of Olfactory Disorders in Patients With Cardiac Amyloidosis","phase":"NA","overall_status":"COMPLETED","enrollment_count":51,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT04789499","title":"Smell in Covid-19 and Efficacy of Nasal Theophylline","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":51,"lead_sponsor_name":"Washington University School of Medicine","has_results":true},{"nct_id":"NCT06817499","title":"Treatment of Olfactory Dysfunction Using Vagus Nerve Stimulation","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":40,"lead_sponsor_name":"Karolinska Institutet","has_results":false},{"nct_id":"NCT05461365","title":"Intranasal Insulin for COVID-19-related Smell Loss","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":27,"lead_sponsor_name":"Universidad Panamericana","has_results":false},{"nct_id":"NCT05445921","title":"Stellate Ganglion Block for COVID-19-Induced Olfactory Dysfunction","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Washington University School of Medicine","has_results":true},{"nct_id":"NCT05970731","title":"Directed Topical Drug Delivery for Treatment for PASC Hyposmia","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":16,"lead_sponsor_name":"Duke University","has_results":true}],"total":18},"guidelines":[],"source":"Drug Landscape verified database"}